Closing Bell: Medicenna Therapeutics Corp down on Friday (MDNA)

Today during trading, shares of Medicenna Therapeutics Corp opened at $1.91 and closed at $1.90. It traded at a low of $1.85 to a high of $1.94.

Shares eased -2.06 percent from the previous day's close of $1.94.

Today across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 47,299 shares was traded during the session, with total trades of 117, with an average volume of 60,006 over 5 days.

Trading across the entire TSX saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 52 weeks, Medicenna Therapeutics Corp's shares have risen 216.67%, while they have risen 352.38% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $145.07 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp's consensus rating is "Strong Buy" based on 2 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..